{"id":"W4405364984","doi":"10.1016/j.msard.2024.106120","title":"159. Cladribine Tablets Use in People with Multiple Sclerosis Up to 4 Years and Beyond Following Treatment Initiation: Results from Multi-country Patient Support Programmes","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Multiple sclerosis; Relapsing remitting; Pediatrics; Physical therapy; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009298035,0.0002442789,0.000566763,0.000603025,0.0005284227,0.0005698574,0.000475572,0.0007252849,0.002616053],"category_scores_gemma":[0.003506969,0.0002339622,0.0009603364,0.0008657819,0.0001798539,0.0005192791,0.0006638438,0.0004441403,0.0005312564],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004934126,"about_ca_system_score_gemma":0.0007601854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009943941,"about_ca_topic_score_gemma":0.01300953,"domain_scores_codex":[0.9993688,0.0003116189,0.00008282529,0.00005078144,0.00007740431,0.0001085146],"domain_scores_gemma":[0.9974226,0.0007279331,0.0009381822,0.00009111059,0.0003064736,0.0005137021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.022226,0.005148287,0.8487427,0.001241229,0.0006424109,0.0003099206,0.001264665,0.0003257266,0.002016532,0.00003777657,0.001767329,0.1162774],"study_design_scores_gemma":[0.0009559361,0.003891282,0.9936576,0.000060992,0.0002713858,0.00005960299,0.0003705487,0.000084946,0.0002024526,0.000009448819,0.0004243717,0.00001135985],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958686,0.0005014833,0.00003351314,0.0001468921,0.00002362045,0.0002694333,0.002037365,0.00001247098,0.001106667],"genre_scores_gemma":[0.996367,0.0004785752,0.0002111821,0.0001908637,0.00002236601,0.0003370845,0.00150823,0.000002428811,0.0008822305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009943941,"threshold_uncertainty_score":0.01977211,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02897219515397852,"score_gpt":0.2474376461445344,"score_spread":0.2184654509905558,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}